Morris, John C.
National Cancer Institute · Center for Cancer Research
2 papers on CoChatORCID 0000-0002-8183-751X
Most cited papers
- Verified
Phase I study of GC1008 (fresolimumab): a human anti‐transforming growth factor‐beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma
Morris, J. C., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Reiss, M., Hsu, F. J., Berzofsky, J. A., & Lawrence, D. P. (2014) · PLoS ONE
TGF-β signaling in diseasesCancer Immunotherapy and Biomarkers
Cited by 487
- Verified
Advances in interleukin 2 receptor targeted treatment
Morris, J. C., & Waldmann, T. A. (2000) · Annals of the Rheumatic Diseases
T-cell and B-cell ImmunologyCytokine Signaling Pathways and Interactions
Cited by 131
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free